Webinar: Early-stage planning for cell and gene therapy launch

The cell and gene therapy space is advancing rapidly, and early, strategic planning is essential to navigate its unique complexities. From regulatory hurdles and evolving payer expectations to limited durability data and small patient populations, CGT developers are facing a distinct set of challenges that require careful groundwork well ahead of launch. 

Tap into Avalere Health’s market access, policy, and medical affairs expertise with an hour-long webinar recording that covers the pre-launch strategies that set the foundation for long-term commercial success. 

We discuss:

• Regulatory navigation and clinical trials: FDA pathways, EMA and APAC considerations, and clinical trial design for market access 

• Market access and reimbursement planning: Payer landscape assessments, early pricing strategy, and outcomes-based contracting 

• Evidence strategy and medical communications: Closing evidence gaps and building credible clinical narratives for HCPs and payers 

• Global policy considerations: HTA submissions, international access strategies, and equity of access 

• Patient and provider engagement: Journey mapping, advocacy group engagement, and site-of-care planning